Similar articles

• Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor.

  Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley LJ, Kohlenberg SH, Castro KG, Dahan BA, Schable CA, et al. Simonds RJ, et al. N Engl J Med. 1992 Mar 12;326(11):726-32. doi: 10.1056/NEJM199203123261102. N Engl J Med. 1992. PMID: 1738377
• [Immunological and cytochemical changes in groups at risk for acquired immunodeficiency syndrome and in symptomatic and asymptomatic carriers of antibodies to human immunodeficiency virus. A multivariate study].

  Gutiérrez Martín M, Romero Colás MS, Callén Sevilla L, Lasierra Díaz P, Larrad Mur L. Gutiérrez Martín M, et al. Med Clin (Barc). 1987 Oct 24;89(13):544-8. Med Clin (Barc). 1987. PMID: 3320599 Spanish. No abstract available.
• [Virologic considerations in donor selection for allogeneic keratoplasty].

  Bialasiewicz AA, Naumann GO, Jahn GJ. Bialasiewicz AA, et al. Klin Monbl Augenheilkd. 1988 Jun;192(6):634-6. doi: 10.1055/s-2008-1050196. Klin Monbl Augenheilkd. 1988. PMID: 3062243 German.
• Review of the risk of HIV infection through corneal transplantation in the United States.

  Caron MJ, Wilson R. Caron MJ, et al. J Am Optom Assoc. 1994 Mar;65(3):173-8. J Am Optom Assoc. 1994. PMID: 8201168 Review.
• [Human immunodeficiency virus (HIV). 1: Transmission and risk of infection].

  Lätzsch I. Lätzsch I. Z Arztl Fortbild (Jena). 1988;82(12):547-51. Z Arztl Fortbild (Jena). 1988. PMID: 3051709 Review. German. No abstract available.